2018
DOI: 10.1016/j.acra.2017.11.012
|View full text |Cite
|
Sign up to set email alerts
|

Dynamic CTA in Native Kidneys Using a Multiphase CT Protocol—Potential of Significant Reduction of Contrast Medium

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…Computed tomography angiography (CTA), magnetic resonance angiography (MRA), X-ray arteriography, Doppler blood vessel ultrasound, and other related technologies provide a pivotal imaging basis for the analysis of blood vessel structure, and consequently play a crucial diagnostic role in diseases involving renal vessels, coronary vessels, liver vessels, and so on [6][7][8]. However, there is still a considerable gap between the collected imaging data and the actual lesions.…”
Section: Introductionmentioning
confidence: 99%
“…Computed tomography angiography (CTA), magnetic resonance angiography (MRA), X-ray arteriography, Doppler blood vessel ultrasound, and other related technologies provide a pivotal imaging basis for the analysis of blood vessel structure, and consequently play a crucial diagnostic role in diseases involving renal vessels, coronary vessels, liver vessels, and so on [6][7][8]. However, there is still a considerable gap between the collected imaging data and the actual lesions.…”
Section: Introductionmentioning
confidence: 99%
“…Several researchers are pioneering miniaturized, novel methods as point-of-care alternatives to flow cytometry, including fluorescent microfluidics for nucleic acid and protein quantification [19][20][21] , droplet-based microfluidics for secreted biomarker analysis 17,22,23 , planar microarrays with micro-engraving techniques for temporal cell behavior evaluation [24][25][26][27] , and barcoded microchip devices for membrane and cytosolic protein detection [28][29][30] . Such proceedings can be directed for treating complicated and changing diseases requiring multiple biomarker determinations like sepsis 5,7,15,31,32 , HIV/AIDS 9,[33][34][35] , acute kidney injury [36][37][38] , urinary tract infections 12,22 , and malignant tumors 26,30,[39][40][41] . While these technologies may provide adequate capabilities in future developments, many are still lacking in adaptive biomarker targeting, low-cost manufacturing, or reducing blood sample volumes required for testing 7,17,18,42 .…”
mentioning
confidence: 99%